Adly Thebaud, MD
Psychiatry · Orange City, FLNPI 1629049770
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,279 of the $3,415 with a category attached, or 66.7%. 3 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 52.1% of the total. Reporting peaked in 2023 at $1,779 and has fallen 98.7% since, to $24 in 2024.
Across 20 payments — averaging $170.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- Pfizer$2K
- AbbVie$24
Across 626 payments — averaging $2775.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$417K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$219K
- Sage Therapeutics, LLC$211K
- Boehringer Ingelheim$209K
- Supernus Pharmaceuticals, Inc.$180K
- F. Hoffmann-la Roche AG$98K
- plus $402K from 14 others
What the payments were for
- Travel & lodging$2,27967%
- Food & beverage$1,13633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 14 | $1,779 |
| Pfizer | 5 | $1,612 |
| AbbVie | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GEODON$1,612
How this compares
$3,415 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Orange City
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.